Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carbohydrate Metabolism, Inborn Errors | 8 | 2018 | 39 | 1.620 |
Why?
|
| Breath Tests | 12 | 2018 | 173 | 1.520 |
Why?
|
| Helicobacter Infections | 14 | 2020 | 1183 | 1.500 |
Why?
|
| Helicobacter pylori | 14 | 2020 | 1260 | 1.310 |
Why?
|
| Caliciviridae Infections | 12 | 2023 | 285 | 1.120 |
Why?
|
| Sucrase-Isomaltase Complex | 6 | 2018 | 20 | 1.030 |
Why?
|
| Esomeprazole | 2 | 2018 | 31 | 0.950 |
Why?
|
| Starch | 5 | 2018 | 28 | 0.910 |
Why?
|
| Norwalk virus | 9 | 2015 | 127 | 0.890 |
Why?
|
| Disaccharidases | 2 | 2020 | 17 | 0.870 |
Why?
|
| Malabsorption Syndromes | 3 | 2020 | 45 | 0.870 |
Why?
|
| Gastroenteritis | 9 | 2023 | 310 | 0.830 |
Why?
|
| Gastrointestinal Agents | 2 | 2018 | 115 | 0.740 |
Why?
|
| Digestion | 4 | 2018 | 40 | 0.710 |
Why?
|
| Immunoenzyme Techniques | 2 | 2020 | 1162 | 0.660 |
Why?
|
| Sucrose | 3 | 2016 | 61 | 0.650 |
Why?
|
| Enzyme Therapy | 1 | 2018 | 6 | 0.650 |
Why?
|
| Feces | 5 | 2023 | 799 | 0.640 |
Why?
|
| Lactobacillus delbrueckii | 1 | 2018 | 2 | 0.630 |
Why?
|
| Antigens, Bacterial | 2 | 2020 | 350 | 0.610 |
Why?
|
| Point-of-Care Systems | 3 | 2006 | 212 | 0.610 |
Why?
|
| Crohn Disease | 5 | 2024 | 317 | 0.610 |
Why?
|
| Norovirus | 5 | 2023 | 290 | 0.590 |
Why?
|
| Urea | 6 | 2009 | 277 | 0.560 |
Why?
|
| Dietary Carbohydrates | 3 | 2012 | 126 | 0.530 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2018 | 204 | 0.520 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 600 | 0.490 |
Why?
|
| Cells | 1 | 2014 | 32 | 0.470 |
Why?
|
| Glucose | 4 | 2020 | 1216 | 0.450 |
Why?
|
| Antibodies, Viral | 7 | 2015 | 1196 | 0.440 |
Why?
|
| Anti-Bacterial Agents | 3 | 2018 | 3057 | 0.430 |
Why?
|
| Carbon Isotopes | 7 | 2018 | 334 | 0.400 |
Why?
|
| Cytoplasm | 1 | 2014 | 642 | 0.400 |
Why?
|
| Intestinal Mucosa | 6 | 2019 | 1065 | 0.400 |
Why?
|
| Intestine, Small | 4 | 2024 | 496 | 0.380 |
Why?
|
| Colon | 3 | 2024 | 661 | 0.360 |
Why?
|
| Amoxicillin | 2 | 2010 | 108 | 0.350 |
Why?
|
| Abdominal Pain | 1 | 2012 | 368 | 0.350 |
Why?
|
| Cell Nucleus | 1 | 2014 | 1608 | 0.320 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2005 | 33 | 0.310 |
Why?
|
| Fasting | 2 | 2020 | 337 | 0.310 |
Why?
|
| Virus Cultivation | 2 | 2019 | 57 | 0.300 |
Why?
|
| Duodenum | 2 | 2018 | 148 | 0.290 |
Why?
|
| Antibodies, Bacterial | 4 | 2006 | 359 | 0.280 |
Why?
|
| Colitis, Ulcerative | 3 | 2015 | 249 | 0.270 |
Why?
|
| Gastric Mucosa | 3 | 2006 | 588 | 0.250 |
Why?
|
| Virus Replication | 3 | 2019 | 678 | 0.240 |
Why?
|
| Bacteriological Techniques | 1 | 2005 | 116 | 0.230 |
Why?
|
| Humans | 59 | 2024 | 262697 | 0.210 |
Why?
|
| Immunoglobulin G | 6 | 2015 | 1019 | 0.210 |
Why?
|
| Adult | 32 | 2021 | 78789 | 0.210 |
Why?
|
| Male | 40 | 2024 | 124154 | 0.200 |
Why?
|
| Urease | 2 | 2020 | 58 | 0.200 |
Why?
|
| Gastric Emptying | 2 | 2021 | 99 | 0.190 |
Why?
|
| Virus Shedding | 4 | 2023 | 82 | 0.190 |
Why?
|
| Viral Vaccines | 2 | 2015 | 292 | 0.180 |
Why?
|
| Biomarkers | 6 | 2020 | 5028 | 0.180 |
Why?
|
| Immunoglobulin A | 4 | 2015 | 234 | 0.180 |
Why?
|
| Liver Cirrhosis | 2 | 2018 | 984 | 0.180 |
Why?
|
| Gastroparesis | 1 | 2021 | 81 | 0.180 |
Why?
|
| Fermentation | 1 | 2020 | 67 | 0.180 |
Why?
|
| Sucrase | 2 | 2017 | 22 | 0.170 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 5009 | 0.170 |
Why?
|
| Female | 35 | 2021 | 143767 | 0.170 |
Why?
|
| Circadian Clocks | 1 | 2020 | 60 | 0.170 |
Why?
|
| Prospective Studies | 7 | 2020 | 12960 | 0.160 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 6033 | 0.160 |
Why?
|
| Postprandial Period | 1 | 2018 | 82 | 0.160 |
Why?
|
| Millets | 1 | 2018 | 1 | 0.160 |
Why?
|
| Sorghum | 1 | 2018 | 3 | 0.160 |
Why?
|
| Middle Aged | 27 | 2020 | 87462 | 0.150 |
Why?
|
| Proton Pump Inhibitors | 3 | 2010 | 251 | 0.150 |
Why?
|
| Satiety Response | 1 | 2018 | 33 | 0.150 |
Why?
|
| Rural Health | 1 | 2018 | 50 | 0.150 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 5 | 0.150 |
Why?
|
| Seeds | 1 | 2018 | 42 | 0.150 |
Why?
|
| Biopsy | 5 | 2020 | 3399 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 2 | 2018 | 589 | 0.150 |
Why?
|
| Cystatin C | 1 | 2018 | 58 | 0.150 |
Why?
|
| Dyspepsia | 1 | 2018 | 103 | 0.150 |
Why?
|
| Saliva | 2 | 2015 | 235 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 366 | 0.140 |
Why?
|
| Proteome | 1 | 2020 | 567 | 0.140 |
Why?
|
| Adolescent | 17 | 2021 | 31577 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2024 | 1989 | 0.130 |
Why?
|
| Stem Cells | 2 | 2019 | 1184 | 0.130 |
Why?
|
| Vaccines, Virus-Like Particle | 1 | 2015 | 34 | 0.120 |
Why?
|
| Dietary Supplements | 2 | 2017 | 564 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 310 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 241 | 0.120 |
Why?
|
| Pancreas | 1 | 2018 | 717 | 0.120 |
Why?
|
| Blood Cells | 1 | 2015 | 121 | 0.120 |
Why?
|
| Cross Reactions | 1 | 2014 | 246 | 0.120 |
Why?
|
| Subcellular Fractions | 1 | 2014 | 197 | 0.120 |
Why?
|
| Metabolomics | 1 | 2017 | 503 | 0.120 |
Why?
|
| Cytosol | 1 | 2014 | 233 | 0.110 |
Why?
|
| Organoids | 1 | 2016 | 299 | 0.110 |
Why?
|
| Brain Death | 1 | 2013 | 54 | 0.110 |
Why?
|
| Young Adult | 9 | 2020 | 21749 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 689 | 0.110 |
Why?
|
| DNA Methylation | 2 | 2014 | 2694 | 0.110 |
Why?
|
| Rotavirus Infections | 1 | 2015 | 286 | 0.110 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 122 | 0.110 |
Why?
|
| Rotavirus | 1 | 2015 | 376 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 1850 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2019 | 1798 | 0.100 |
Why?
|
| Hemagglutination, Viral | 1 | 2011 | 10 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2013 | 250 | 0.100 |
Why?
|
| Aged | 12 | 2020 | 71287 | 0.100 |
Why?
|
| Protein Transport | 1 | 2014 | 728 | 0.100 |
Why?
|
| Fluoroimmunoassay | 1 | 2011 | 7 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2012 | 344 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2018 | 5896 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2015 | 765 | 0.100 |
Why?
|
| Enteral Nutrition | 1 | 2013 | 333 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2010 | 554 | 0.090 |
Why?
|
| Siblings | 1 | 2012 | 287 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 946 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2020 | 2795 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 511 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2012 | 249 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 1316 | 0.090 |
Why?
|
| Antigens, Viral | 1 | 2012 | 438 | 0.090 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 89 | 0.090 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2010 | 19 | 0.090 |
Why?
|
| Child | 10 | 2023 | 29575 | 0.090 |
Why?
|
| Serologic Tests | 2 | 2011 | 137 | 0.090 |
Why?
|
| Diet | 1 | 2018 | 1457 | 0.090 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 80 | 0.090 |
Why?
|
| beta-Fructofuranosidase | 1 | 2009 | 3 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2007 | 358 | 0.080 |
Why?
|
| Endoscopy, Digestive System | 2 | 2018 | 197 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 2136 | 0.080 |
Why?
|
| Inflammation | 2 | 2020 | 2479 | 0.080 |
Why?
|
| Liver | 1 | 2017 | 2915 | 0.080 |
Why?
|
| alpha-Glucosidases | 1 | 2007 | 32 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 345 | 0.070 |
Why?
|
| Primary Health Care | 2 | 2005 | 813 | 0.070 |
Why?
|
| Capsule Endoscopy | 1 | 2007 | 26 | 0.070 |
Why?
|
| Galactosemias | 1 | 2006 | 15 | 0.070 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 417 | 0.070 |
Why?
|
| Galactose | 1 | 2006 | 79 | 0.070 |
Why?
|
| Cell Line | 1 | 2014 | 5001 | 0.070 |
Why?
|
| Pepsinogen C | 1 | 2006 | 12 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2006 | 67 | 0.070 |
Why?
|
| Pepsinogen A | 1 | 2006 | 19 | 0.070 |
Why?
|
| Jejunum | 1 | 2007 | 216 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 2455 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2006 | 122 | 0.060 |
Why?
|
| Models, Biological | 1 | 2014 | 3130 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2366 | 0.060 |
Why?
|
| Acetazolamide | 1 | 2005 | 37 | 0.060 |
Why?
|
| Freezing | 1 | 2005 | 57 | 0.060 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2005 | 27 | 0.060 |
Why?
|
| Mucus | 1 | 2005 | 108 | 0.060 |
Why?
|
| Anesthesia, Local | 1 | 2005 | 59 | 0.060 |
Why?
|
| Ulcer | 1 | 2005 | 73 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 2261 | 0.060 |
Why?
|
| Child, Preschool | 7 | 2018 | 16396 | 0.060 |
Why?
|
| Culture Media | 1 | 2005 | 309 | 0.060 |
Why?
|
| Histamine H2 Antagonists | 1 | 2004 | 50 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 1425 | 0.060 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 122 | 0.060 |
Why?
|
| Placebos | 2 | 2015 | 434 | 0.060 |
Why?
|
| Temperature | 1 | 2005 | 481 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2014 | 4060 | 0.050 |
Why?
|
| Foreign-Body Migration | 1 | 2004 | 114 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2005 | 298 | 0.050 |
Why?
|
| Anti-Ulcer Agents | 1 | 2003 | 99 | 0.050 |
Why?
|
| Omeprazole | 1 | 2003 | 87 | 0.050 |
Why?
|
| Intussusception | 1 | 2003 | 52 | 0.050 |
Why?
|
| United States | 3 | 2010 | 15693 | 0.050 |
Why?
|
| Celiac Disease | 1 | 2003 | 73 | 0.050 |
Why?
|
| Office Visits | 1 | 2002 | 94 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 156 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 574 | 0.050 |
Why?
|
| Granuloma | 1 | 2023 | 152 | 0.050 |
Why?
|
| Time Factors | 5 | 2023 | 12669 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2015 | 2879 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2002 | 207 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 522 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2004 | 336 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 5327 | 0.040 |
Why?
|
| Kinetics | 1 | 2023 | 2016 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2021 | 633 | 0.040 |
Why?
|
| Triglycerides | 1 | 2002 | 587 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 178 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 534 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 545 | 0.040 |
Why?
|
| Sex Factors | 2 | 2018 | 2107 | 0.040 |
Why?
|
| Cholesterol | 1 | 2002 | 635 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2005 | 1345 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 236 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2023 | 1019 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2020 | 267 | 0.040 |
Why?
|
| Plant Tubers | 1 | 2018 | 1 | 0.040 |
Why?
|
| Mali | 1 | 2018 | 10 | 0.040 |
Why?
|
| Solanum tuberosum | 1 | 2018 | 14 | 0.040 |
Why?
|
| Triticum | 1 | 2018 | 33 | 0.040 |
Why?
|
| Immune System | 1 | 2020 | 273 | 0.040 |
Why?
|
| Oryza | 1 | 2018 | 32 | 0.040 |
Why?
|
| Sirolimus | 1 | 2002 | 809 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 382 | 0.040 |
Why?
|
| Urban Health | 1 | 2018 | 75 | 0.040 |
Why?
|
| Shrews | 1 | 2017 | 5 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2015 | 2538 | 0.040 |
Why?
|
| Food Preferences | 1 | 2018 | 120 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 297 | 0.040 |
Why?
|
| Bile | 1 | 2016 | 82 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 486 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 443 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 760 | 0.030 |
Why?
|
| Enterocytes | 1 | 2016 | 75 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2014 | 11940 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2017 | 33142 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 398 | 0.030 |
Why?
|
| Infant | 4 | 2018 | 13468 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 692 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 1402 | 0.030 |
Why?
|
| Creatinine | 1 | 2018 | 533 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2015 | 53 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2020 | 1139 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 147 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 105 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 953 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 389 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 573 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 1557 | 0.030 |
Why?
|
| False Negative Reactions | 2 | 2004 | 277 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2013 | 213 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 1247 | 0.030 |
Why?
|
| Mutation | 1 | 2012 | 15383 | 0.030 |
Why?
|
| Human Experimentation | 1 | 2012 | 49 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 4254 | 0.030 |
Why?
|
| Proteomics | 1 | 2020 | 1412 | 0.030 |
Why?
|
| Fathers | 1 | 2012 | 71 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 1853 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2011 | 123 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 6204 | 0.020 |
Why?
|
| Immunoassay | 1 | 2012 | 204 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2012 | 125 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2012 | 93 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2011 | 172 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 1493 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 38842 | 0.020 |
Why?
|
| Graft Survival | 1 | 2013 | 1055 | 0.020 |
Why?
|
| Taiwan | 1 | 2009 | 96 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 844 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 174 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2010 | 188 | 0.020 |
Why?
|
| Clarithromycin | 1 | 2009 | 114 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 990 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1133 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 293 | 0.020 |
Why?
|
| Isomaltose | 1 | 2007 | 1 | 0.020 |
Why?
|
| Acarbose | 1 | 2007 | 3 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2013 | 989 | 0.020 |
Why?
|
| Maltose | 1 | 2007 | 18 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 4254 | 0.020 |
Why?
|
| Galactitol | 1 | 2006 | 2 | 0.020 |
Why?
|
| Galactosephosphates | 1 | 2006 | 4 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 3936 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 1430 | 0.020 |
Why?
|
| Animals | 3 | 2020 | 59528 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1997 | 0.020 |
Why?
|
| Lactose | 1 | 2006 | 63 | 0.020 |
Why?
|
| Pepsinogens | 1 | 2006 | 11 | 0.020 |
Why?
|
| Endoscopy | 1 | 2009 | 471 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 457 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 1388 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 3467 | 0.020 |
Why?
|
| Gastrins | 1 | 2006 | 50 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1923 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2008 | 652 | 0.020 |
Why?
|
| Gastroscopy | 1 | 2006 | 139 | 0.020 |
Why?
|
| Mexico | 1 | 2006 | 260 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 4762 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2006 | 195 | 0.020 |
Why?
|
| Atrophy | 1 | 2006 | 243 | 0.020 |
Why?
|
| Family Health | 1 | 2006 | 309 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 351 | 0.020 |
Why?
|
| Capsules | 1 | 2005 | 53 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2010 | 8270 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 676 | 0.010 |
Why?
|
| Famotidine | 1 | 2004 | 15 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 2063 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 337 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 3949 | 0.010 |
Why?
|
| Citric Acid | 1 | 2004 | 52 | 0.010 |
Why?
|
| Mice | 2 | 2020 | 34706 | 0.010 |
Why?
|
| Arthritis | 1 | 2005 | 141 | 0.010 |
Why?
|
| Sodium Bicarbonate | 1 | 2004 | 58 | 0.010 |
Why?
|
| Imidazoles | 1 | 2009 | 1035 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 2003 | 115 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 621 | 0.010 |
Why?
|
| Video Recording | 1 | 2005 | 268 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 838 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 4775 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 9234 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 963 | 0.010 |
Why?
|
| Gastritis | 1 | 2004 | 338 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 1656 | 0.010 |
Why?
|
| Stomach | 1 | 2003 | 379 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 5705 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2003 | 1019 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 3522 | 0.010 |
Why?
|
| Texas | 1 | 2010 | 6275 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 5669 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 4414 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 30243 | 0.010 |
Why?
|
| Veterans | 1 | 2004 | 1720 | 0.010 |
Why?
|